Table 1

- Height velocity by gender across various intervals in patients receiving somapacitan therapy.

IntervalsFemaleMaleP-values
12 weeks8.82±5.238.96±5.150.800
24 weeks8.05±3.958.58±3.720.499
36 weeks8.91±3.658.73±2.560.831
72 weeks7.83±5.807.88±1.730.603

Values are presented as mean ± standard deviation (SD).